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CHARACTERISTICS OF LONG-ACTING REVERSIBLE CONTRACEPTION 
USERS PRESENTING TO A PEDIATRIC EMERGENCY DEPARTMENT  
 
HALEA KALA MEESE 
ABSTRACT 
Background: One in ten sexually active adolescents in the United States become 
pregnant each year. Significant differences in unintended pregnancy and use of long-
acting reversible contraceptive (LARC) methods: the sub-dermal implant, the copper 
intrauterine device (IUD) and hormonal IUDs, exist between socioeconomic strata as 
well as ethnic and racial groups. Women using LARC are 20 times	  less	  likely	  to	  experience	  a	  pregnancy	  than	  women	  using	  short-­‐acting	  reversible	  methods. Thus, 
LARCs present a major opportunity for the prevention of unintended pregnancy.  
Purpose: Characterize contraceptive use, demographics, and behavioral characteristics of 
a novel population: young women presenting to an urban Pediatric Emergency 
Department (PED) in order to better understand the contraceptive needs of this 
population.  
Methods: We characterized the current LARC usage. Using an anonymous paper-based 
questionnaire, we surveyed women ages 16-21 years regardless of chief complaint 
presenting to our PED regarding their demographics, health care access, sexual history, 
and history of contraceptive use. We conducted a cross-sectional analysis of demographic 
characteristics for current LARC and non-LARC users (n=331) using chi-squared for 
categorical variables and student’s t-test for continuous variables.  
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Results: No significant differences were found between women currently using LARC 
and those not using LARC, however current LARC usage in our population was 15.8%, 
about three times that documented in the most recent national studies conducted in 2013.  
Conclusion: Current LARC use is particularly high in our urban PED setting. More 
research is necessary to determine if this is part of a larger national trend or if the early 
implementation of no-cost contraception in Massachusetts and changes in provider or 
patient attitudes towards LARC may explain the large observed difference in LARC 
usage. 
 
Key words: contraceptive implant, intrauterine device, long-acting reversible 
contraception, pediatric emergency department, adolescent
	  	   vii	  
 
TABLE OF CONTENTS 
 
TITLE……………………………………………………………………………………...i 
COPYRIGHT PAGE……………………………………………………………………...ii 
READER APPROVAL PAGE…………………………………………………………..iii 
ACKNOWLEDGMENTS ................................................................................................. iv	  
ABSTRACT ........................................................................................................................ v	  
TABLE OF CONTENTS .................................................................................................. vii	  
LIST OF TABLES ............................................................................................................. ix	  
LIST OF FIGURES ............................................................................................................ x	  
LIST OF ABBREVIATIONS ............................................................................................ xi	  
INTRODUCTION .............................................................................................................. 1	  
BACKGROUND ................................................................................................................ 3	  
Adolescent Sexual Behavior ........................................................................................... 3	  
Adolescent Pregnancy ..................................................................................................... 5	  
Adolescent Contraception ............................................................................................... 6	  
Adolescent Primary Care Utilization ............................................................................ 11	  
Clinical Recommendations and Provider Attitudes ...................................................... 13	  
Types of LARC Currently Available ............................................................................ 14	  
Advantages of LARC .................................................................................................... 18	  
	  	   viii	  
History of LARC and Women of Color ........................................................................ 19	  
Study Setting ................................................................................................................. 20	  
Summary ....................................................................................................................... 22	  
SPECIFIC AIMS .............................................................................................................. 24	  
METHODS ....................................................................................................................... 25	  
Study Design ................................................................................................................. 25	  
Study Population ........................................................................................................... 25	  
Recruitment and Data Collection .................................................................................. 26	  
Survey Instrument ......................................................................................................... 26	  
Data Analysis ................................................................................................................ 27	  
RESULTS ......................................................................................................................... 28	  
DISCUSSION ................................................................................................................... 32	  
APPENDIX A Study Script .............................................................................................. 36	  
APPENDIX B Guardian Information Sheet ..................................................................... 37	  
APPENDIX C Survey ....................................................................................................... 38	  
REFERENCES ................................................................................................................. 41	  
CURRICULUM VITAE ................................................................................................... 62	  
 
  
	  	   ix	  
LIST OF TABLES 
 
 
Table Title Page 
1 Baseline Respondent Characteristics 29 
2 Unadjusted Odds Ratios of Current LARC Use 31 
 
  
	  	   x	  
LIST OF FIGURES 
 
 
 
Figure Title Page 
1 Provider and Patient Concerns about LARC 19 
 
 
  
	  	   xi	  
LIST OF ABBREVIATIONS 
 
AAFP ................................................................. American Academy of Family Physicians  
AAP ................................................................................. American Academy of Pediatrics  
ACA ...................................................................................................... Affordable Care Act 
ACOG ........................................... American Congress of Obstetricians and Gynecologists  
BMC  ................................................................................................ Boston Medical Center 
BUMC  ......................................................................... Boston University Medical Campus  
CDC  ................................................................ Centers for Disease Control and Prevention  
DMPA ........................................................ Depot medroxyprogesterone acetate, “the shot”  
ED .................................................................................................... Emergency department 
GED .......................................................................... General educational development test  
IUD ......................................................................................................... Intrauterine device 
....... (unless otherwise mentioned refers to all formulations of hormonal and copper IUDs) 
LARC ......................................................................... Long-acting reversible contraception 
NSFG  ............................................................................ National Survey of Family Growth 
OCP .................................................................................................... Oral contraceptive pill  
........... (this includes both combined pills and progestin-only pills unless otherwise stated) 
PCP .................................................................................................... Primary care provider  
PED .................................................................................... Pediatric emergency department  
PID ........................................................................................... Pelvic inflammatory disease  
PRI ..................................................................................................... Pregnancy Risk Index  
SARC ......................................................................... Short-acting reversible contraception  
	  	   xii	  
SIECUS  ....................... Sexuality Information and Education Council of the United States 
STI ........................................................................................ Sexually transmitted infection 
UN  ................................................................................................................ United Nations 
YRBSS  .............................................................. Youth Risk Behavior Surveillance System 
	  1 
INTRODUCTION 
 
 Unintended pregnancy remains an issue of significant concern in the United 
States. Of sexually active U.S. adolescent females, more than 1 in 10 become pregnant 
each year (Kost & Henshaw, 2014). Over the last two decades, adolescents have waited 
longer until first sexual intercourse and rates of condom and oral contraceptive pill (OCP) 
usage at last intercourse have improved modestly, but the rate of teen pregnancy in the 
U.S. remains 2-10 times the rates of other economically similar nations (Kann et al., 
2014; Singh & Darroch, 2000). Within the U.S. there are significant racial differences 
with Black women experiencing an unintended pregnancy rate almost 200% higher and 
Hispanic women with a rate about 170% higher than White women (Kost & Henshaw, 
2014). 
Part of the disparity in teenage pregnancy between the U.S. and economically 
similar European nations may be accounted for by the lower rate of contraception use by 
U.S. adolescents, both in terms of short-acting reversible contraception (SARC) and long-
acting reversible contraception (LARC). SARC methods as defined by the American 
Congress of Obstetricians and Gynecologists (ACOG) include condoms, OCPs, 
contraceptive patches, vaginal rings, and the depot medroxyprogesterone (DMPA) shot, 
while long-acting methods include intrauterine devices (IUDs), copper and hormonal, and 
sub-dermal implants (American Congress of Obstetricians and Gynecologists, 2012). Of 
school enrolled U.S. adolescent females, 22.4% reported use of OCPs for contraception at 
last intercourse compared to 55% of 15 year-old females in Germany, 32% in Canada, 
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and 23% in England (Currie, Gabhainn, & Godeau, 2008; Kann et al., 2014).  U.S. 
women use IUDs at less than half of the rate of Northern and Western European women 
(UN Department of Economic and Social Affairs, Population Division, 2011). The form 
of birth control used is of crucial importance as risk of pregnancy was measured at 16-20 
times higher for women using SARC as compared to those using a long-acting method 
(Winner et al., 2012). Additionally, failure rates in the U.S. and Canada for oral 
contraceptive pills and for vaginal rings are higher than in Europe, likely due to 
differences in compliance (Mansour, Inki, & Gemzell-Danielsson, 2010). Increased 
access to LARC could help to prevent unintended pregnancies and close the gap between 
ethnic, racial, and socioeconomic groups within the U.S. as well as the gap between the 
U.S. and its European counterparts.  	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BACKGROUND 	  
Adolescent Sexual Behavior  	  
In the U.S., the average age at first intercourse for women is 17.1 years with 27% 
of 15-17 year-old females and 62.7% of 18-19 year-old females reporting they have ever 
had intercourse (CDC, 2013). Rates of adolescent sexual intercourse are slightly higher in 
African American females and Hispanic females, 53.4% and 46.9% respectively, as 
compared to 45.3% of white females (Kann et al., 2014). Though adolescents have 
continued to delay sexual initiation and use protection at higher rates over the past two 
decades, with 85.6% of adolescent females now reporting use of contraception at last 
intercourse compared to 79.9% in 1988, usage rates and reports of risk behavior have 
stagnated during the two most recent years of data (CDC, 2011).  
Social factors modify adolescent sexual behavior and may impact subsequent 
health outcomes. Lower socioeconomic status contributes to risk of earlier sexual 
initiation (O’Donnell, O’Donnell, & Stueve, 2001). Family structure differing from two 
biological parents has been documented as a significant factor in earlier sexual initiation, 
however it does not significantly impact lifetime risk of sexually transmitted infection 
(STI), concurrent sexual partners, or exchange of sex for money during the last year 
(O’Donnell et al., 2001; Haydon, Herring, & Halpern, 2012). Obesity is also a risk factor 
in some groups, particularly White females where it increases the likelihood of having 
multiple sexual partners and decreases likelihood of condom usage (Leech & Dias, 2012). 
Early initiators, defined as those with a sexual debut at less than 15 years, are more likely 
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to report multiple sexual partners, pregnancy, and forced intercourse (Magnusson, Masho, 
& Lapane, 2012; O’Donnell et al., 2001). The educational prospects of early sexual 
initiators, with a sexual debut prior to age 15, tend to be the most heavily impacted; they 
are significantly less likely to graduate from high school, enroll in college, and graduate 
from college, even sexual initiation before age 18 has also been associated with reduced 
odds of post-secondary education (Spriggs & Halpern, 2008; Steward, Farkas, & 
Bingenheimer, 2009).  
Certain characteristics and behaviors may serve as protective factors that may 
delay sexual initiation and increase the likelihood that condoms will be used at first 
sexual intercourse. In a systematic review of the effects of spirituality and social norms 
on adolescent sexual health, subjective sexual norms (the attitudes, beliefs, or values of 
survey participants towards sex), perceived sexual norms (the participants’ perception of 
the norms of others), and religiosity (attendance at services and importance of 
spirituality) were found to be protective of ever having had sex, use of condom, and 
intention to have sex (House, Mueller, Reininger, Brown, & Markham, 2010).  Factors 
previously thought of as protective, such as college aspirations, may not actually mediate 
likelihood of sexual initiation or unprotected sexual activity, though one study found a 
significant difference in recent sexual activity between low and high aspiring students 
(Cubbin, Brindis, Jain, Santelli, & Braveman, 2010; Kirk, Lewis, Lee, & Stowell, 2011). 
Pledges of virginity have not been found to be effective at delaying onset of sexual 
activity or to have an effect on STI history and adolescent women who pledge virginity 
are less likely to report birth control usage at last sex (Rosenbaum, 2009).   
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Adolescent Pregnancy  	  
The United States unintended pregnancy rate is 147 per 1,000 in sexually active 
women 15-17 years of age and 162 per 1,000 in sexually active women aged 18-19, 
significantly higher than in similarly developed nations (Finer, 2010; Singh & Darroch, 
2000). Women with a mother or sister who has experienced teenage pregnancy are 
significantly more likely to experience teenage pregnancy themselves (East, Reyes, & 
Horn, 2007; Magnusson, Masho, & Lapane, 2011). Across all races and ethnicities, early 
menarche significantly increases the probability that an adolescent will experience 
pregnancy (Dunbar, Sheeder, Lezotte, Dabelea, & Stevens-Simon, 2008). Additionally, 
low socioeconomic status, Black race or Latina ethnicity are also associated with 
unintended pregnancy (Gillespie, Ahmed, Tsui, & Radloff, 2007; Magnusson et al., 
2011). Homeless youth constitute an especially vulnerable population with regards to 
adolescent pregnancy with reported rates ten times the national average (Winetrobe et al., 
2013; Kost & Henshaw, 2014).  
Barriers to the reduction of adolescent pregnancy may be largely attitudinal: 
ambivalence to pregnancy has been documented as high as 30% in urban females and 
odds of ambivalence increase with reported depression (Chernick, Kharbanda, Santelli, & 
Dayan, 2012; Francis, Malbon, Braun-Courville, Lourdes, & Santelli, 2014). Other 
attitudes such as low self-worth and hopelessness are also associated with attempted 
pregnancy (Fedorowicz, Hellerstedt, Schreiner, & Bolland, 2014).  
Though overall teen pregnancy and birthrates have decreased in recent years, 
initiatives focused on pregnancy reduction can continue to build on these successes. The 
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National Initiative to Prevent Teen Pregnancy successfully reduced teen pregnancy by a 
third during the decade after its founding in 1996; the initiative now has been expanded 
to focus on unintended pregnancy as there have not been significant gains in this area 
(National Campaign to Prevent Teen Pregnancy, 2015). Other initiatives, such as The 
President’s Teen Pregnancy Prevention Initiative, focus on communities with the highest 
rates of adolescent pregnancy with the aim to reduce teen birth rates by 10%, delay first 
sex, increase the use of effective means of contraception, and reduce the overall teen 
pregnancy rate (SIECUS, 2012). In addition to initiatives explicitly focused on pregnancy 
prevention, initiatives that focus on early childhood education and youth development in 
the form of academic support, after school programs, and community service also show 
promise for the reduction of adolescent pregnancy; a recent systematic review found a 
pooled 39% reduction (Harden, Brunton, Fletcher, & Oakley, 2009).  
 
Adolescent Contraception   	  
General Use  
Overall, American adolescent female contraception usage has improved from 
79.9% in 1988 to 85.6% today (Centers for Disease Control and Prevention (CDC), 2011). 
The overall rate is comparable with available data for Canada, England, and France 
whose rates were 82.3, 82.8, and 89.5 respectively (Godeau et al., 2008). However, use of 
contraception at last intercourse still varies considerably depending on race and ethnicity: 
89.3% of non-Hispanic white adolescent females reported using some method of 
contraception at last intercourse while only 81.1% of non-Hispanic Blacks and 79.5% of 
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Hispanic/Latinas reported doing so (CDC, 2011). Even of those women using 
contraception, 23% of U.S. women experience relatively high risk of pregnancy due to 
inconsistent use (Frost, Singh, & Finer, 2007). Additionally, early sexual debut increases 
the odds of gaps in the use of contraception by two times compared to women who 
debuted at 18 years of age or later and increases likelihood of nonuse at most recent 
intercourse (Magnusson et al., 2011, 2012; Cavazos-Rehg et al., 2010). Family conflict is 
also associated with not using contraception at last intercourse and an increased number 
of sexual partners (Lyerly & Brunner Huber, 2013). Though ambivalence to pregnancy 
contributes to a woman’s odds of pregnancy, women with high levels of ambivalence 
have not been found to differ in contraceptive use from non-ambivalent women (Yoo, 
Guzzo, & Hayford, 2014). As with pregnancy, attitudinal factors play a significant role in 
use of contraception: in a worldwide systematic review of qualitative studies, authors 
found a number of universal themes in adolescent beliefs regarding sexual behavior. 
Themes included: condoms are stigmatizing and indicate lack of trust, partners and 
societal norms influence behavior, adolescents tend to assess their partners as “clean” or 
“dirty”, and social norms may hinder communication about sex (Marston & King, 2006). 
These attitudinal factors may help to explain low usage of birth control methods among 
adolescents despite a high degree of knowledge.  
 
Adolescent Knowledge of contraception  
Condoms and OCPs are the most common forms of contraception in the 
adolescent population, however this may not constitute a preference, but a lack of 
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knowledge regarding other types of contraception as women are unlikely to choose a 
method with which they are unfamiliar (CDC, 2011; Spies, Askelson, Gelman, & Losch, 
2010). Though most adolescents have heard of OCPs and condoms, misconceptions 
persist, even among OCP users (Craig, Dehlendorf, Borrero, Harper, & Rocca, 2014; 
Hamani et al., 2007). However, increased knowledge of oral contraceptives was 
associated with significantly higher 6 month continuation rates (Hall, Castaño, & 
Westhoff, 2014). Lesser known methods of SARC, such as the ring and the patch, benefit 
particularly from provider counseling, which is associated with higher rates of women 
choosing these methods (Harper, Brown, Foster-Rosales, & Raine, 2010). Hispanic 
women are considerably less likely to have heard of the patch, the ring, and IUDs while 
Black women were less likely to have heard of the ring (Craig et al., 2014).  
Differences in awareness about contraceptive methods remain: 87% of 
adolescents have heard of IUDs and only 52% have heard of implants, as opposed to near 
100% awareness of OCPs and condoms (Craig et al., 2014). Women are frequently 
misinformed about IUDs and are unaware that nulliparous women are eligible to use 
them, though this may in part be due to the fact the most popular form of hormonal IUD, 
Mirena®, is not labeled for use in nulliparous women in the U.S. (Craig et al., 2014; 
Finer, Jerman, & Kavanaugh, 2012). Younger women and non-native English speakers 
were significantly less likely to have heard of LARC and have low level knowledge of 
LARC methods (Craig et al., 2014; A. R. Dempsey, Billingsley, Savage, & Korte, 2012; 
Sokkary et al., 2013).  Nulliparous women are initially less likely to be interested in an 
IUD, but are more likely to consider an IUD after provider counseling (Fleming, Sokoloff, 
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& Raine, 2010). The largest prospective observational study to date, which offered 
counseling followed by a choice of all reversible types of contraception, shows that 
improved knowledge about LARC leads to increased use and acceptability in the 
adolescent and young adult population (Mestad et al., 2011). Overall, 70% of participants 
chose a LARC method. A significant majority of 14-17 year-olds preferred the implant 
while a significant majority of 18-20 year-olds chose hormonal or copper IUDs (Mestad 
et al., 2011). Despite the generally high awareness of SARC, continued emphasis should 
be placed on increasing knowledge of all forms of contraception to increase uptake and 
continuation rates among adolescents and young adults.  
 
Adolescent Usage of Contraception  
Nearly sixty percent of sexually active school-attending adolescents reported they 
or their partner used a condom at last intercourse to prevent pregnancy, 19% reported 
OCP use, and 1.6% reported IUD or implant use (Kann et al., 2014). Overall, these usage 
rates still fall behind most European nations (United Nations, 2011). Racial differences in 
LARC usage vary for adolescents as compared to young adults; adolescent Black women 
are significantly less likely to use LARC than their white counterparts, while among 
young adults, Asian women are the only group significantly less likely to use a LARC 
method (Dehlendorf et al., 2014; Dempsey et al., 2012). The disparity in contraceptive 
usage rates between white women and women of color has broadened in recent years 
(Dehlendorf et al., 2014; Jacobs & Stanfors, 2013). Parous women are considerably more 
likely to use an IUD than nulliparous women (Whitaker, Sisco, Tomlinson, Dude, & 
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Martins, 2013; Xu et al., 2011). Predictive factors for current LARC usage in young 
women (18-29 years of age) include higher age, earlier onset of sexual activity, less than 
four sexual partners in the last year, and higher education level of the mother of the user 
(A. R. Dempsey et al., 2012; Xu et al., 2011). Women with previous history of 
discrimination are more likely to use SARC, but when barriers to contraception were 
removed, women tend to choose LARC (Kossler et al., 2011). Research regarding the 
indication for LARC usage in the adolescent female population is also lacking. In a 
review of clinical trials and observational studies examining female contraceptives, 
studies that examined LARC methods were significantly less likely to recruit nulliparous 
females than trials examining OCPs, instead limiting recruitment to white women of 
more advanced age (Mansour et al., 2010).  
Adolescent beliefs regarding bleeding patterns may also influence contraceptive 
choice. Adolescent women noted irregular bleeding as a common concern, especially the 
disruption of menses as it was frequently seen as a process necessary for the "cleansing" 
of the body or otherwise in opposition to cultural beliefs (Clark, Barnes-Harper, Ginsburg, 
Holmes, & Schwarz, 2006; Kavanaugh, Frohwirth, Jerman, Popkin, & Ethier, 
2013). Changes in menstruation also caused the adolescents to doubt the effectiveness of 
the contraceptive method (Clark et al., 2006).  
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Adolescent Primary Care Utilization  	  
Overall, 16-20% of adolescent girls lack access to primary care and are more 
likely to report no regular source of health care as compared to children (McKee & 
Fletcher, 2006; Schoen, Davis, & Scott Collins, 1997; Burns & Leininger, 2012). 
Minority adolescent females, particularly Asian adolescents, are less likely to have a 
usual source of care as are women born outside the mainland U.S., those with lower 
maternal education, and those who are not sexually active (McKee & Fletcher, 2006; 
Schoen et al., 1997). Of females with access to primary care, the primary care setting also 
differed by race: Black and Hispanic females disproportionately access hospital 
outpatient clinics as their source of primary care, while white females disproportionately 
access non-hospital based physicians’ offices for their primary care (Hoover, Tao, 
Berman, & Kent, 2010).  
Younger girls tend to see pediatricians for their primary care, but by 17-18 years 
of age, women are significantly more likely to see an OB/GYN (Hoover et al., 2010). 
Privately insured and Medicaid covered adolescent females alike are likely to go multiple 
years without a preventive care visit, but do access primary care for problem focused 
visits more than once per year (Nordin, Solberg, & Parker, 2010; Dempsey & Freed, 
2010).  Even when girls access primary care, their needs are not met; although two thirds 
of adolescent girls surveyed said that doctors should discuss sensitive issues such as 
pregnancy prevention, less than a quarter reported discussing these types of topics 
(Schoen et al., 1997).  
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Adolescents and young adults more frequently access the emergency department 
(ED) in place of a primary care provider (PCP) for non-urgent health care needs as 
compared to children and older adults (Uscher-Pines, Pines, Kellermann, Gillen, & 
Mehrotra, 2013; Ziv, Boulet, & Slap, 1998). Nationally, African Americans, females, and 
18-21 year-olds account for a disproportionately high amount of ED usage compared to 
their proportion of the total population (Ziv et al., 1998). Adolescents who use the ED as 
their usual source of care were more likely to report missed care and fewer regular 
preventive health visits (Wilson & Klein, 2000). Higher risk groups of adolescents such 
as those reporting high risk behaviors and clinical history significant for depression and 
sexual abuse were are all more likely to use the ED as their usual source of care (Wilson 
& Klein, 2000). Non-urgent patients express a variety of reasons for accessing emergency 
services including: urgent need to seek medical attention, referral by PCP, and shorter 
wait times (Weiss, D’Angelo, & Rucker, 2014).  A substantial portion of women 
presenting to the PED feel it is an acceptable place to receive contraception or related 
information, with the majority of women preferring a location such as the PED over their 
physician’s office (Todd, Plantinga, & Lichenstein, 2005). Women who would prefer to 
receive contraception or related information in a setting other than their physician’s office 
are significantly more likely to be uninsured and lack a PCP (Todd et al., 2005).  
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Clinical Recommendations and Provider Attitudes  	  
In the past, providers were not amenable to prescribing LARC methods to 
adolescents; however, with recent revisions in the professional recommendations of the 
ACOG, American Academy of Pediatrics (AAP) and American Academy of Family 
Physicians (AAFP), these beliefs are slowly changing. ACOG came forward in 2012 with 
the first and the strongest worded opinion indicating that LARC should “be first-line 
recommendations for all women and adolescents”, though the AAFP and most recently 
the AAP have approved similar recommendations (American Congress of Obstetricians 
and Gynecologists, 2012; Randel, 2012; American Academy of Pediatrics, 2014). In 
keeping with these changes, physicians with training in OB/GYN or family medicine are 
significantly more likely to prescribe LARC than their pediatric or internal medicine 
trained counterparts (Greenberg, Makino, & Coles, 2013). More providers consider IUDs 
and implants safe for adolescents than in previous years; however many providers still 
fail to discusses these options with as many as half of their patients (Biggs, Harper, 
Malvin, & Brindis, 2014; Kavanaugh, Jerman, Ethier, & Moskosky, 2013; Wellings, 
Zhihong, Krentel, Barrett, & Glasier, 2007). Providers are more likely to discuss these 
options at facilities where staff had received training on delivery of contraception to 
adolescents and with patients of older age (Kavanaugh, Jerman, et al., 2013). Providers 
tend to be more reluctant to discuss IUD provision when the provider sees the patient as 
promiscuous or who puts herself at undue risk for STIs (Rubin, Campos, & Markens, 
2013). Additionally, providers tend to have unfounded concerns, such as that methods 
will cause infertility, will have higher rates of non-compliance than other methods, or that 
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nulliparous women are not good candidates for the method (Kavanaugh, Jerman, et al., 
2013; Madden, Allsworth, Hladky, Secura, & Peipert, 2010; Swanson, Gossett, & 
Fournier, 2013) Many providers also express concerns about experience in inserting 
implants and most frequently, concern about the cost of both IUDs and implants to the 
clinic and to the patient (Kavanaugh, Jerman, et al., 2013). Though cost concerns have 
disappeared for many patients under the Affordable Care Act (ACA), many private 
insurers are denying certain methods of birth control such as the patch and the ring 
arguing that these are not distinct methods as they use the same hormone levels found in 
OCPs (Sonfield, 2013). Obtaining contraception may be especially difficult for 
immigrant women as those who have not had legal residence for 5 years are unable to 
qualify for Medicaid (National Latina Institute for Reproductive Health, 2010). Physician 
knowledge, willingness to prescribe, and cost all may impede wider adoption of LARC in 
the adolescent population.   
 
Types of LARC Currently Available  	  
The Implant 
Nexplanon®, “the implant”, is a 4 cm long cylindrical implant that is placed under 
the skin of the upper arm providing a continuous release of etonogestrel 68mg for three 
years (Merck, 2011). The failure rate is extremely low, less than one pregnancy per 100 
women in one year, but greater than 10% of women experience irregular bleeding, with 
the majority of women experiencing fewer than average days of bleeding, but some 
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experiencing more (Mansour, Bahamondes, Critchley, Darney, & Fraser, 2011; Merck, 
2011). The 24 month discontinuation rate in trials conducted both in the U.S. and abroad 
ranges from 27-75%, with the most common reason due to irregular bleeding (Arribas-
Mir et al., 2009; Harvey, Seib, & Lucke, 2009; Lakha & Glasier, 2006; O’Neil-Callahan, 
Peipert, Zhao, Madden, & Secura, 2013). Many women express that they were not 
adequately warned of all side effects prior to initiation of the implant, thus side-effect 
counseling particularly regarding bleeding patterns is extremely important and in some 
studies has led to improved rates of continuation (Davie et al., 1996; Hoggart, Louise 
Newton, & Dickson, 2013). However, in other settings, more “intensive” counseling has 
had no effect (Modesto, Bahamondes, & Bahamondes, 2014). Latina, Black, White and 
Asian women differ in their belief that it is necessary to have a period every month with 
ethnic and cultural factors possibly accounting for some of the differences (Andrist et al., 
2004; Mansour et al., 2011). Black women and Hispanic women were more likely to hold 
this belief as compared to White women which may partially account of lower usage of 
LARC among Black and Hispanic women (Andrist et al., 2004; Zheng, Zheng, Qian, 
Sang, & Kaper, 1999). As the implant is the only externally visible form of LARC, some 
women note concerns of privacy as it may be visible under the skin, but others report that 
their male partners find its appearance reassuring (Meirik, Fraser, d’ Arcangues, & WHO 
Consultation on Implantable Contraceptives for Women, 2003). Indonesians and 
Ethiopians may insert objects or herbs under the skin for beautification or medicinal 
purposes thus adoption of the implant may be increased in these cultures (Meirik et al., 
2003) 
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In addition to the low failure rate and the length of duration of action, the implant 
has other advantages, particularly regarding its insertion. The implant is more likely to be 
placed before an adolescent mother resumes sexual intercourse as compared to the IUD, 
likely due to recommendations regarding IUD placement that dictate that placement 
should occur within 48 hours of birth or after four weeks (Tocce, Sheeder, Python, & 
Teal, 2012). Implants are also advantageous over IUDs in that they can be placed after 
any abortion, not just abortions that occur in the first or second trimester (American 
Congress of Obstetricians and Gynecologists, 2012). Implants also have the potential to 
be administered by a wider number of specialists and generalists as they require 
considerably less extensive training than IUDs (Potter, Koyama, & Coles, 2015).  
 
The IUD  
Three types of intrauterine devices are currently available in the United States: the 
ParaGard® copper IUD, the Mirena® IUD (a levonorgestrel-releasing form), and most 
recently the Skyla® low-dose levonorgestrel-releasing IUD (Prescott & Matthews, 2014). 
A fourth type of IUD, marketed as GyneFix®, a frameless copper IUD, does not differ 
significantly from the conventional framed IUD in any of the characteristics measured 
(O’Brien & Marfleet, 2005).  All methods are very effective with less than one percent of 
women experiencing pregnancy with one year of use and are also readily reversible with 
70% of women able to conceive in the year after removal (Prescott & Matthews, 2014). 
Adolescents and young women discontinue IUD use for a spectrum of reasons including 
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pain, bleeding, infection, expulsion, pregnancy desire, and partner sensation of strings 
(Lara-Torre, Spotswood, Correia, & Weiss, 2011; Teal & Sheeder, 2012). The twelve 
month discontinuation rate for adolescent women is significantly higher than women over 
25 years of age, with estimates ranging from 23-45% (Aoun et al., 2014; Teal & Sheeder, 
2012). Rates of expulsion, contraceptive failure, and discontinuation at 12 months are all 
significantly increased with the copper IUD compared to the hormonal (Aoun et al., 
2014).  
An IUD is advantageous in that it may be inserted same day post abortion, 
however, this leads to significantly higher expulsion rates compared to delayed insertion 
(Okusanya, Oduwole, & Effa, 2014). IUDs are also effective for other uses than routine 
contraception: the copper IUD is the most effective form of emergency contraception and 
hormonal IUDs are the most effective minimally invasive treatment of menorrhagia 
(Koyama, Hagopian, & Linden, 2013; Turok et al., 2013; American Academy of 
Pediatrics, 2014; Qiu, Cheng, Wang, & Hua, 2014).  
 
Injectable  
Medroxyprogesterone acetate, Depo-Provera®, “the shot”, is considered a form of 
LARC by the National Institute of Health Care Excellence in the UK since it is a means 
of contraception that is administered less than once a month, but is not included by major 
physician groups in the United States (American Congress of Obstetricians and 
Gynecologists, 2012; Randel, 2012; National Collaborating Centre for Women’s and 
Children’s Health (UK), 2005). Medroxyprogesterone acetate is administered by a health 
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professional as an intramuscular injection every 3 months (Pfizer, 2010). Part of the 
controversy over the long or short-acting classification of this method is borne out by the 
large difference between typical use and perfect use pregnancy rates: with typical use the 
1 year pregnancy rate is 3%, but with perfect use this rate is only 0.3% and is comparable 
to the implant and all types of IUD (Curtis, 2010). Additionally, the shot is not currently 
recommended as method of contraception for greater than two years due to its risk of 
bone mineralization loss (Curtis, 2010). Depo-Provera® has the highest 12 and 24 month 
discontinuation rate of all hormonal methods of contraception, a relationship that is not 
significantly altered by allowing user self-injection (Curtis, 2010; OʼNeil-Callahan, 
Peipert, Zhao, Madden, & Secura, 2013; Cameron, Glasier, & Johnstone, 2012). The 
most common reason for discontinuation is irregular bleeding followed by breast 
tenderness and weight gain (Drey & Darney, 2002). The shot is not as readily reversible 
as other methods of contraception as ovulation resumes on average 200 days after the last 
shot (Drey & Darney, 2002). Despite these side effects, medroxyprogesterone injection is 
especially useful in certain patient populations such as epileptics and sickle cell patients 
as it has been shown to reduce seizures and decrease hemolytic crisis (Drey & Darney, 
2002). 
Advantages of LARC  	  
Overall, LARC methods are seen as the preferred contraceptive for the adolescent 
population by providers, but are not yet the method of choice among patients. Providers 
and patients agree that the “forgettable” nature of this method of contraception is an 
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important advantage and that possibility of painful insertion and removal is a major 
disadvantage (Figure 1) (Kavanaugh, Frohwirth, et al., 2013). However, providers do not 
tend to share the patient’s chief concern, having a foreign object in her body, which may 
be a major barrier to adolescent uptake of LARCs (Kavanaugh, Frohwirth, et al., 2013).  
LARC’s may help to lessen the female’s burden of responsibility of contraception, as 
many women feel that this responsibility is not shared by their partner (Hodgson, Collier, 
Hayes, Curry, & Fraenkel, 2013). 
 
Figure 1: Provider and Patient Concerns about LARC from Kavanaugh, Frohwirth, et al., 2013.  
 	  
History of LARC and Women of Color 	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Though all major physician professional groups have issued resolutions in support 
of LARC use in adolescents, we should proceed with awareness of the history of one 
form of LARC, Norplant®, in communities of color. In the early 1990’s, Norplant®, the 
six-rod original formulation of the sub-dermal implant, was suggested by American 
political groups as a method for sterilizing women on Welfare (Thompson, 1996; Roberts, 
1998). Allegations of providers refusing LARC removal have also surfaced, as have 
assertions of providers specifically administering the device to women with “social 
problems” (Thompson, 1996). Indeed, Black and Native American women have 
historically used Norplant® at rates much higher than their White and Asian counterparts 
(Malat, 2000).  In administering LARCs, providers should take care to preserve female 
autonomy and ensure that removal is readily available when desired by the patient. 
 
Study Setting 	  
The state of Massachusetts has among the lowest teenage pregnancy and birth 
rates in the nation and has seen considerable declines in adolescent pregnancy, birth, and 
abortion rates since state data was first recorded in 1988 (Kost & Henshaw, 2014). 
However, the overall statistics mask considerable inequality: the Hispanic birthrate is 
more than four times and the birthrate for Blacks is nearly three times the birthrate for 
non-Hispanic Whites (Kost & Henshaw, 2014). 
A third of Black and Hispanic females presenting to a New York City urban PED 
were currently pregnant or at significant risk of pregnancy over the next year according to 
a calculated Pregnancy Risk Index (PRI) based on the efficacy of a woman’s 
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contraceptive method assuming typical use (Chernick et al., 2012). About a quarter of 
women seen in this ED were amenable to hearing about contraception during their visit; 
women with a higher PRI were more amenable to receiving information (Chernick et al., 
2012). 	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Summary 	  
In sum, many characteristics such as race and ethnicity, as well as social, 
behavioral, and biological factors affect the sexual behavior, pregnancy, and 
contraception practices of adolescents. U.S. adolescents now wait longer until first sexual 
intercourse, though additional factors such as family structure, body weight, social norms, 
spirituality, and educational aspirations all modify sexual behavior. In overall sexual 
behavior U.S. adolescents do not significantly differ from other similarly developed 
nations, but the adolescent pregnancy rate remains significantly higher. Differences in 
contraceptive usage may play a role as U.S. women use both LARC and SARC methods 
of contraception at a lower rate than women in Northern and Western Europe. Social 
factors such as ambivalence to pregnancy, mother or sister who experienced adolescent 
pregnancy, and homelessness as well as biological factors such as early menarche 
contribute to elevated risk of adolescent pregnancy. Americans also differ from other 
similarly developed nations in their contraceptive choice; overall use rates are similar but 
American adolescent women tend to favor short acting methods which carry with them a 
higher risk of pregnancy as compared to extremely low risk LARCs. Factors such as 
knowledge about LARC, early sexual debut, family conflict, partner norms, and history 
of discrimination have been documented as influencing this choice. Improved patient 
knowledge about LARC leads to increased use, increased satisfaction, and lower rates of 
discontinuation. Previous research indicates that women are amenable to discussing 
LARC in the ED. Young women frequently lack access to primary care, which helps to 
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explain the disproportionately high rates of ED usage for African Americans and 18-21 
year olds as well as those with history of depression and sexual abuse.  
Previously, providers were reluctant to administer LARCs to adolescent females, 
but in the past three years all the professional organizations of the physicians most likely 
to administer LARCs to adolescents (ACOG, AAP, and AAFP) have endorsed the use of 
LARCs as first-line contraceptives for sexually active women. Despite the changes in 
recommendations, misconceptions remain common and many physicians report that they 
are uncomfortable with LARC administration procedures. Advantages perceived by 
providers do not perfectly match the concerns of patients, though both agree that the fact 
that LARCs are forgettable, long-lasting, and have beneficial side effects are major 
selling points.  
The previous literature identifies a need to better characterize women presenting 
to urban PEDs and their current contraceptive use as these women may come from some 
of the groups most vulnerable to unintended teenage pregnancy and may otherwise lack a 
means of obtaining a LARC method.  
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SPECIFIC AIMS 	  
Aim 1: Describe characteristics of young women presenting to an urban PED who 
currently use a LARC method.  
Hypotheses: We predict that users of long-acting methods presenting to an urban PED 
will have similar characteristics as women presenting to family planning clinics and 
women included in large national surveys. 
Methods: We will compute descriptive statistics for LARC users, non-LARC users, and 
total population.  	  
Aim 2: Compare current LARC users and current non-LARC users presenting to an 
urban PED.  
Hypothesis: We predict that women who use LARC will be older, have higher gravidity, 
increased parental education, increased history of STI, and decreased level of education. 
Methods: We will use chi-square tests to compare categorical variables (race, ethnicity, 
parental education, educational aspirations, primary care usage, and STI history) and t-
tests to compare continuous variables (age and gravidity). We will also compute odds 
ratios.
	  25 
METHODS 
 
Study Design 	  
We conducted a cross-sectional anonymous paper-based questionnaire study in an 
urban PED in Boston, Massachusetts. This study, which aimed to characterize the 
demographic and behavioral characteristics of current LARC users presenting to the PED, 
is a subset of a larger study aiming to characterize contraceptive use and preferences in 
order to improve contraceptive options in the PED. LARC methods include the 
levonorgestrel IUDs, the copper IUD, and the subdermal implant. Non-LARC methods 
include all other types of contraception and women not currently using a contraceptive 
method. The study was approved by the Institutional Review Board of Boston University 
Medical Campus (BUMC) and granted a Waiver of Requirement for Documentation of 
Consent. 
 
Study Population 	  
The PED at Boston Medical Center (BMC) serves an ethnically and racially 
diverse population of almost 27,000 patients per year. Inclusion criteria were such that all 
English-speaking females 16-21 years of age regardless of chief complaint presenting to 
the PED during a survey block period were approached regarding study participation. 
Women with high acuity complaints, who were medically comprised, or those with 
intellectual disability were excluded from the study. Additionally, women unable to read 
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in English and those women in custody of the Department of Children and Families or 
the Department of Youth Services were also excluded. 
 
Recruitment and Data Collection 	  
The study is a convenience sample of women from the Boston area enrolled from 
August 2014 until December 2014. Study staff used a standardized script to obtain verbal 
informed consent from the patient prior to administration of the survey (Appendix A). 
Waiver of parental consent was not required for minors as women in Massachusetts are 
lawfully allowed to make decisions relating to reproductive health at age 16. Research 
assistants were present during periods of high eligible patient volume (12pm-11pm daily) 
as determined by the previous experience of the study author (A.K.).  
Women completed the survey in private rooms and if accompanied by a parent, or 
guardian, he or she was asked to step outside while the patient completed the survey. Any 
study participant who wished to give her parent(s)/guardian(s) information about the 
study, was provided a printed study information sheet (Appendix B).  
 
Survey Instrument  
 
A twenty-question paper questionnaire was administered (Appendix C). The 
survey instrument was piloted with 10 women to confirm face validity. The questionnaire 
provides information on patient demographics, primary care usage, contraceptive usage, 
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willingness to discuss or start contraception in the PED, and sexual and reproductive 
history.  
 
Data Analysis  	  
We performed a cross-sectional analysis of the questionnaire data collected from 
a total of 384 participants. Descriptive statistics were computed for study participants. 
Demographic characteristics for current LARC and non-LARC users were compared 
using chi-squared for categorical variables, student’s t-test for continuous variables, and 
logistic regression for multivariate analyses.  Fischer’s Exact tests and Mann-Whitney U 
tests were used when appropriate. Odds ratios were also calculated. All factors that were 
significant in bivariate analysis were included in multivariate analysis. P Values and 95% 
CIs were used to describe statistical significance. All data was pre-coded and entered by 
research assistants using Microsoft Excel 2011 for Mac version 14.4.4. Data analysis was 
performed using SPSS software Statistics 20.0 (SPSS Inc., Chicago, IL).  	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RESULTS 
 
Of the 384 women who completed the survey, 330 provided sufficient 
information for inclusion in our analysis of current LARC usage.  Only 15.8% of women 
(52/331) reported current usage of a LARC method, 57.7% (30/52) used IUDs and 42.3% 
(22/52) used implants. LARC user characteristics were similar to those of the study 
population as a whole: the mean age was 19.2 years, 64% identified as African American, 
44.2% had attended some college or received a 2 year college education (Associate’s 
degree), 39.5% had parents who had completed high school, 44.0% planned to complete 
a 4 year college degree, 53.1% presented to the PED for a Gynecological/ Genitourinary 
or Gastrointestinal complaint, 86.5% indicated having a PCP, 79.2% had seen their PCP 
in the past year, 66.0% had no previous history of STI, and 63.3% were nulliparous 
(Table 1). The race of baseline respondent characteristics was divided into Black/African 
American, White/Caucasian, and Asian or Mixed/Other because of the very small 
proportion of Asian survey respondents and the high number of mixed race respondents 
(Table 1). Respondents were included in the Mixed/Other category if they marked 
multiple races (Black/African American, White/Caucasian, and/or Asian) or if they chose 
Other. The most commonly specified other race was Hispanic/Latina (17) with an 
additional 15 respondents specifying Cape Verdean.  
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Table 1: Baseline Respondent Characteristics  
   
Frequency 
(%) 
 
  
Current 
LARC 
Users n=52 
Current 
Non-LARC 
Users 
n=278 
Total 
Population 
n=330 
Age, mean 19.2 ± 1.4 19.1 ± 1.5 19.2 ± 1.5 
Ethnicity 
    
 
Hispanic/Latina/Spanish 18 (34.6) 66 (24.1) 85 (26.1) 
Race  
    
 
Black/African American 32 (64.0) 144 (54.5) 177 (56.0) 
 
White/Caucasian 3 (6.0) 44 (16.5) 47 (14.9) 
 
Asian or Mixed/Other 15 (30.0) 78 (29.2) 93 (29.3) 
Level of Education    
 
Less than high school 17 (32.7) 85 (31.6) 103 (31.8) 
 
High School Graduate or GED  12 (23.1) 101 (37.1) 113 (34.9) 
 
Some College but no degree or 
2-year college degree 
(Associate's Degree)  
23 (44.2) 85 (31.3) 108 (33.3) 
Parent Level of Education     
 
Less than high school 5 (9.6) 34 (14.8) 39 (14.3) 
 
High School Graduate or GED  17 (39.5) 89 (38.7) 106 (38.8) 
 
Some College but no degree or 
2-year college degree 
(Associate's Degree)  
13 (30.2) 47 (20.4) 60 (22.0) 
 
4 year college graduate (BA, 
BS) or Graduate/Professional 
School 
8 (18.6) 60 (26.1) 68 (24.9) 
Planned Level of Education     
 
High School Graduate or GED 
or 2-year college degree 
(Associate's Degree) 
9 (18.0) 52 (21.2) 61 (20.7) 
 
4 year college graduate (BA, 
BS) 22 (44.0) 115 (47.3) 138 (46.8) 
 
Graduate or Professional School 19 (38.0) 77 (31.4) 96 (32.5) 
Chief Complaint*     
 
Gynecological/Genitourinary  9  (19.1) 44 (17.4) 58 (16.8) 
 
Gastrointestinal  16 (34.0) 71 (28.1) 97 (28.1) 
 
Other  26 (55.3) 151 (59.7) 207 (53.8) 
*Participants were permitted to list multiple chief complaints   
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Table 1 continued: Baseline Respondent Characteristics  
  
Current 
LARC 
Users n=52 
Current 
Non-LARC 
Users 
n=278 
Total 
Population 
n=330 
Has Primary Care Provider     
 
Yes  45 (86.5) 229 (84.5) 274 (84.8) 
 
No  7 (13.5) 42 (15.5) 49 (15.2) 
Last time saw PCP    
 
Within the past year  38 (79.2)  194 (78.9) 232 (78.9) 
 
A year or more ago 10 (20.8) 52 (21.1) 62 (21.1) 
Previous History of STI    
 
Yes  17 (34.0) 84 (31.5) 101 (31.9) 
 
No 33 (66.0) 183 (68.5) 216 (68.1) 
Gravidity     
     
 
0 31 (63.3) 188 (69.1) 219 (68.2) 
 
1 12 (24.5) 43 (15.8) 55 (17.1) 
 
2 or more 6 (12.2) 41 (15.1) 47 (14.6) 
Bivariate analysis comparing LARC to non-LARC users showed no significant 
difference in age, race, ethnicity, parental education, educational aspirations, primary 
care usage, gravidity, and STI history between the two groups. Non-LARC users were 
defined as all women not using LARC including women using SARC (condoms, OCPs, 
contraceptive patch, vaginal ring, or the shot) as well as those not using contraception 
(abstinence, withdrawal, or none).  Odds of current LARC use based on age, race, 
ethnicity, parental education, educational aspirations, primary care usage, gravidity or 
STI history also did not significantly differ (Table 2). The race of respondents was further 
combined for bivariate analysis because of the low number of respondents indicating 
White/Caucasian race only. The participant’s education level was not evaluated in 
bivariate analysis as it was highly correlated with participant age. Logistic regression was 
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not performed, as there were no significant differences between current LARC users and 
non-LARC users. 
 
Table 2: Unadjusted Odds Ratios of Current LARC Use   
Table 2: Unadjusted Odds Ratios of Current LARC Use  
 
  
Odds 
Ratio  95% CI 
Age  
   
 
16-17 Reference  
 
 
18-19 1.626 0.652-4.056 
 
20-21 1.152 0.462-2.868 
Ethnicity 
   
 
Hispanic/Latina/Spanish 1.693 0.896-3.201 
 
Non-Hispanic Reference  
 Race  
   
 
Black/African American 1.484 0.793-2.774 
 
White/Caucasian, Asian, or Mixed/Other Reference  
 Parent Level of Education  
  
 
Less than high school Reference 
 
 
High School Graduate or GED  1.299 0.444-3.796 
 
Some College but no degree or 2-year 
college degree (Associate's Degree)  2.07 0.680-6.3 
 
4 year college graduate (BA, BS) or 
Graduate/Professional School 1.037 0.321-3.348 
Planned Level of Education  
  
 
High School Graduate or GED or 2-year 
college degree (Associate's Degree) Reference  
 
 
4 year college graduate (BA, BS) 1.096 0.472-2.543 
 
Graduate or Professional School 1.426 0.599-3.395 
Has Primary Care Provider  
  
 
Yes  1.179 0.498-2.791 
 
No  Reference  
 Last time saw PCP 
  
 
Within the past year  1.019 0.476-2.180 
 
A year or more ago Reference  
 Previous History of STI  
  
 
Yes  1.122 0.592-2.128 
 
No Reference  
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Table 2 continued: Unadjusted Odds Ratios of Current LARC Use   
  
Odds Ratio  95% CI 
Gravidity  
   
 
0 Reference  
 
 
1 1.692 0.804-3.562 
 
2 or more 0.887 0.348-2.266 
 
DISCUSSION 
 
 Though we predicted that LARC users presenting to an urban PED would have 
similar characteristics as women presenting to family planning clinics and women 
included in large national surveys, we found our participants differed from national 
studies such as the NSFG (Nation al Survey of Family Growth), CDC YRBS (Youth Risk 
Behaviour Surveillance System), and Guttmacher Institute as well as the Contraceptive 
CHOICE Project in age, race, ethnicity, and gravidity (Dempsey et al., 2012; Peipert et 
al., 2011; Xu et al., 2011). Participants of our study tend to be younger, and more diverse: 
higher proportions of our participants identify as ethnically Hispanic or racially African 
American or Mixed-Race (Table 1). Additionally, our participants have lower gravidity, 
though we expect this is related to their younger age (Table 1). The parental education of 
our participants was slightly higher than in the NSFG, though in each study the most 
common education level is high school or GED. Other studies did not record participants’ 
educational aspirations or primary care usage; therefore, we are unable to compare our 
results. The population differences can be explained in part by our different setting and 
profile of chief complaints; we are a large urban PED without direct affiliation to a 
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children’s hospital, and unlike family planning clinics, only a small proportion of our 
population, 19.1%, present with gynecological or genitourinary issues (Table 1).  
 At 15.8%, the current LARC usage documented by our study is three times higher 
for this age group than previously documented by local and national surveys (Branum & 
Jones, 2015; Finer et al., 2012; Kann et al., 2014). We believe this dramatic difference in 
current LARC usage could be attributed to a variety of policy and attitudinal factors. Our 
institution has several policies that reduce barriers to LARC access: same-day 
appointments and walk-in appointments for LARC placement are available and some 
providers are trained and amenable to placing the sub-dermal implant in the PED. Other 
policies, such as the requirement for the provision of no-cost contraception under the 
Affordable Care Act (ACA), decrease the financial barriers to LARC uptake. As our 
institution is located in Massachusetts, two events may account for our higher rates of 
LARC usage: firstly, considerable Medicaid expansion occurred in 1997 and thus access 
to no-cost contraception was expanded and secondly, An Act Providing Access to 
Affordable, Quality, Accountable Health Care was passed in 2006 which also increased 
contraceptive coverage, though co-pays were still required (Conaboy & Kotz, 2011; 
Holahan & Blumberg, 2006). All current data includes the period prior to national ACA 
implementation; thus, with the changes specific to Massachusetts, we find that this may 
contribute to the high rates of LARC usage we documented in our study population. 
Further research is needed to determine if the high rate of LARC uptake seen here in our 
PED will be true of the rest of the nation several more years after full implementation of 
the ACA.   
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Practice guidelines for the placement of LARC have also changed: LARC’s are 
considered first-line contraception for sexually active adolescents by major professional 
organizations of American physicians (ACOG, AAP, and AAFP), with the first being 
adopted in 2012 by ACOG. The changes in professional regulations, insurance coverage 
of contraception, and provider education may translate to a greater willingness on the part 
of providers to place LARC in nulliparous young women. As women tend to adopt the 
type of contraception used by their peers and are unlikely to use methods with which they 
are familiar, LARC usage may continue to increase as more women have social contacts 
using LARC and are more educated about these methods (Carter, Bergdall, Henry-Moss, 
Hatfield-Timajchy, & Hock-Long, 2012; Spies et al., 2010).  
Our study faces some limitations, as it was conducted in just one urban PED and 
is a convenience sample, the generalizability of our results may be limited. However, this 
novel population is also a strength: many young women use the ED as their source of 
primary care and a large urban PED has not yet been the subject of other studies aiming 
to characterizing current usage of LARC.  
 The high rate of LARC usage in our population is encouraging for the uptake of 
LARC by young women nationally, but especially because women of color and those 
who have experienced discrimination have historically been less likely to use LARC than 
white women (Dehlendorf et al., 2014; A. R. Dempsey et al., 2012; Kossler et al., 2011). 
As we found no significant differences between young women currently using LARC and 
those not using LARC, we believe that all young women desiring contraception should be 
counseled about the benefits of LARC without emphasis race, ethnicity, education, 
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primary care usage, gravidity or sexual history. Continuing to increase the education of 
both providers and patients will be crucial to ensuring all young women have access to 
the most effective forms of contraception.  
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APPENDIX A Study Script 
If parent(s) are in the room with the patient. 
 
My name is XXXXXX 
I am a member of the research staff here at Boston Medical Center.  
 
We are conducting a research study about reproductive health and birth control. Discussions 
about an adolescent’s reproductive health are confidential, or talked about in private, without 
parents in the room during medical visits. We usually have young women complete this survey in 
private. Are you interested in being in this study? Would you (parent) mind stepping out of the 
room? 
 
(If the patient indicates that she would like her parent to stay in the room, or doesn’t mind her 
parent staying in the room, they may do so.) 
 
We are doing this study to understand the contraceptive, or birth control, needs of young women 
aged 16 to 21 years who come to our Emergency Room. The 20-question survey will take about 5 
to 10 minutes to complete. The survey is anonymous, meaning you will not write your name or 
any other information that could identify you. Your decision to do the survey is voluntary. Your 
care will not change if you choose to participate or not.  
 
Please read the top page of the survey that explains in more detail what I just explained. You may 
give your parent(s) an information sheet describing the study and your participation of the study, 
if you would like. 
 
If parent(s) are not in the room with the patient. 
 
My name is XXXXXX 
I am a member of the research staff here at Boston Medical Center.  
 
We are doing this study to understand the contraceptive, or birth control, needs of young women 
aged 16 to 21 years who come to our Emergency Room. The 20-question survey will take about 5 
to 10 minutes to complete. The survey is anonymous, meaning you will not write your name or 
any other information that could identify you. Your decision to do the survey is voluntary. Your 
care will not change if you choose to participate or not. 
 
Please read the top page of the survey that explains in more detail what I just explained. You may 
give your parent(s) an information sheet describing the study and your participation of the study, 
if you would like. 
 
If adolescent declines participation: 
 
Thank you very much for your time. 
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APPENDIX B Guardian Information Sheet 
Birth Control and Sexual Health 
 
 
What is the research study that my daughter has volunteered for? 
 
Your daughter has volunteered to participate in a research study that lasts just for the period of 
time she is visiting the Pediatric Emergency Department at Boston Medical Center. State of 
Massachusetts guidelines indicate that minors can provide their own consent or permission, 
without parental input, for health-care related decisions regarding matters of reproductive health. 
Along these lines, your daughter was asked if she would be willing to fill out a research 
questionnaire about questions regarding reproductive health choices.  The survey is strictly 
anonymous. No identifying information is provided on the survey, meaning that it will be 
impossible for anyone to know who the answers belong to. 
 
What is the study about? 
 
This is a research study focusing on adolescents’ and young women’s thoughts about birth control 
and their sexual health. The study is being conducted at Boston Medical Center. The purpose of 
this study is to find out more about adolescents’ and young women’s contraceptive needs, 
including whether or not young women may desire contraception from the emergency department. 
The hope is that your daughter’s participation will ultimately help improve medical care.  About 
300 women between the ages of 16 to 21 are being asked to take part in this study.    
 
What will my daughter be doing? 
 
We are asking young women to complete an anonymous questionnaire with 20 questions.     
 
What happens to the information my daughter provides? 
 
We will not record any identifying information. The completed anonymous questionnaires will be 
stored in a safe and secure location in a research study office at Boston Medical Center. 
Information from this study may be reviewed and photocopied by state and federal regulatory 
agencies such as U.S. Government’s Office of Human Research Protection and the Institutional 
Review Board of the Boston University Medical Campus, which oversees the conduct of all 
human subject research at Boston Medical Center. 
 
Who can I contact for more information? 
 
The Institutional Review Board at the Boston University Medical Campus oversees all research 
studies at Boston Medical Center. Please contact them at 617-638-7207 or medirb@bu.edu if 
you have any questions about your daughter being a research subject in this study. 
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APPENDIX C Survey 
Section A: Background Information 
1. How old are you? __________________ years old 
 
2. Are you Hispanic, Latina or of Spanish origin? 
   Yes 
   No 
 
3. What is your race/ethnicity? (Check all that apply.)         
   Black or African American     Asian 
   White or Caucasian      Other: 
________________________________ 
 
4. What is the highest level of education you have completed?   
   Junior high school                      Some college but no degree 
   Some high school     2-year college degree (Associates 
degree) 
   High school graduate or GED    Other: 
________________________________ 
  
5. What is the highest level of education completed by your parent(s)?   
   Less than high school     2-year college degree (Associates 
degree) 
   High school graduate or GED    4-year college graduate (BA, BS) 
   Some college but no degree     Graduate or professional school 
   Don’t know 
 
6. What is the highest level of education you plan to complete?   
   High school graduate or GED    4-year college graduate (BA, BS) 
   2-year college degree (Associates degree)   Graduate or professional school 
   Don’t know 
 
7. Do you have a primary care physician (regular doctor)? 
   Yes 
   No (If no, skip to question 9B) 
 
8. When is the last time you saw your primary care physician (regular doctor)? 
   Within the last year 
   Between 1- 2 years ago 
   Over 2 years ago 
 
9. Have you ever talked about birth control options with your primary care physician (regular 
doctor) and/or a parent? 
 9A) Your doctor:        Yes   9B) A parent:    Yes 
	  39 
                                      No       No 
 
10. What brought you to the ER today? (examples: sore throat, fever, abdominal pain):  
 
______________________________________________________________________________ 
Section B. Sexual Health History and Birth Control 
11. If you were being seen in the emergency room for a problem, even if that problem was not 
related to your sexual health, would you be open to learning about birth control? 
   Yes 
   No  
 
12.  Have you ever been sexually active with boys? (By this, we mean vaginal sex) 
   yes 
   no  (If no, skip to question 15) 
13. What type of birth control are you using now?          Birth control in the past? 
 (Check all that apply.)       (Check all that apply.) 
   Abstinence     Abstinence 
   Birth control pills, ring, or patch    Birth control pills, ring, or patch 
   Injectable (Depo- Provera shot)     Injectable (Depo- Provera shot) 
   IUD (Mirena, Skyla, Copper ParaGard)   IUD (Mirena, Skyla, Copper 
ParaGard) 
   Implantable (Implanon/Nexplanon)   Implantable(Implanon/Nexplanon) 
   Withdrawal method (“pulling out”)    Withdrawal method (“pulling out”) 
   Condoms     Condoms 
   None      None 
   Other: ____________________________   Other: _________________ 
 
14 A. Are you happy w/ your current method of birth control?  
   Yes (If yes, skip to Question 15) 
   No  (If no, continue to Question 14B) 
 
14 B. If no, why not? (examples: requires a doctor visit, irregular bleeding, weight gain, can’t 
remember to take/use.)  
 
 
 
 
15. If you could start or change to any type of birth control of your choice here in the emergency 
room, how likely would you be to start it today? 
 
 Unlikely      Neutral          Likely                 
              1                                2                                3                                4                    5           
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16. Which birth control method(s) would you be willing to start or change to if it was offered to 
you here in the emergency room today. (Check all that apply.) 
   Birth control pills, ring, or patch    
   Injectable (Depo- Provera shot)     
   IUD (Intra uterine device: Mirena, Skyla, Copper ParaGard)     
   Implantable (Implanon/Nexplanon)       
   I’m happy with my birth control method and would not change to a different kind.  
   None 
   Other: ____________________________  
 
17. Have you heard of the implantable birth control device Nexplanon that goes under the skin in 
the upper arm  
       (previously known as Implanon), which is the size of a matchstick and lasts for 3 years)? 
   Yes 
   No (If no, skip to Question 19) 
 
18. How did you hear about Nexplanon?  (Check all that apply.) 
   Friends, family      Media (internet, magazines) 
   Medical professional (School nurse, primary care doctor, nurse, clinic) 
   Other  __________________________ 
 
19. Have you ever been diagnosed with a STD (sexually transmitted disease)? (examples: 
gonorrhea, chlamydia, herpes, trichomoniasis) 
   yes                  no 
 
20. How many times have you been pregnant?  ______________ (list # of times pregnant) 
 
Thank you for taking the time to complete this survey
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Education	  
Master	  of	  Science,	  Medical	  Sciences.	  Expected	  May	  2015	  
Boston	  University	  Master’s	  Thesis	  title:	  “Characteristics	  of	  Long	  Acting	  Reversible	  Contraception	  Users	  	  	   	  Presenting	  to	  a	  Pediatric	  Emergency	  Department”	   
Bachelor	  of	  Arts,	  Public	  Health.	  May	  2012.	  Departmental	  Honors	  
University	  of	  California,	  Berkeley.	  Berkeley,	  California.	  Concentration	  in	  Infectious	  Diseases	  Study-­‐abroad	  term	  at	  University	  of	  Ghana,	  Legon.	  Accra,	  Ghana.	  July	  2010-­‐December	  2010.	  	  	   Honors	  Thesis	  Topic:	  “Economic	  Incentives	  to	  Improve	  Women’s	  Reproductive	  Health:	  A	  	   	  Systematic	  Review”	  
	  
Research	  Experience	  	  
Boston	  Medical	  Center	  Pediatric	  Emergency	  Department,	  Boston,	  MA	  	  	  	  	  	  8/2014-­‐Present	  
Graduate	  Research	  Assistant	  
• Conducted	  more	  than	  100	  surveys	  regarding	  contraception	  and	  sexual	  health	  with	  women	  ages	  16-­‐22	  
• Performed	  statistical	  analysis	  of	  data	  using	  SPSS	  	  
• Findings:	  current	  LARC	  usage	  in	  our	  population	  was	  15.8%,	  about	  three	  times	  that	  documented	  in	  the	  most	  recent	  national	  studies	  
	  
UC	  Berkeley	  School	  of	  Public	  Health,	  Berkeley,	  C	  A	   	  	  	  	  	  	  	  	  	  	  	  	   	   8/2011-­‐7/2012	  
Honors	  Candidate	  in	  Public	  Health	  	  
• Designed	  systematic	  literature	  review	  of	  economic	  incentives	  and	  their	  impact	  on	  women’s	  reproductive	  health	  
• Systematically	  reviewed	  over	  3,000	  publications	  to	  determine	  eligibility	  for	  inclusion	  in	  study	  
• Participated	  in	  bi-­‐weekly	  research	  group	  meetings	  with	  graduate	  students	  and	  professors	  discussing	  studies	  of	  in	  progress	  and	  other	  recently	  published	  work	  	  
• Findings:	  evidence	  available	  is	  too	  heterogeneous	  to	  detect	  an	  impact	  of	  economic	  incentives	  on	  women’s	  reproductive	  health	  	  
	  
Summer	  Undergraduate	  Research	  Fellowship,	  Berkeley,	  CA	   	  	  	  	  	  	  	  	  	  	  	  	   6/2011-­‐8/2011	  
Fellow	  	  
• Designed	  and	  conducted	  systematic	  literature	  review	  of	  demand	  side	  interventions	  for	  the	  prevention	  of	  mother	  to	  child	  transmission	  of	  HIV	  
• Findings:	  Insufficient	  evidence	  to	  determine	  impact	  (only	  one	  study	  met	  inclusion	  criteria)	  
	  
Ridge	  Regional	  Hospital,	  Accra,	  Ghana	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9/2010-­‐12/2010	  	  	  	  	  	  
	   Independent	  Research:	  Out	  of	  Pocket	  Pre	  and	  Post-­‐natal	  Expenditure	  of	  Women	  Living	  with	  
	   HIV	  
• Designed	  study	  and	  questionnaire	  	  
• Conducted	  45	  minute	  patient	  interviews	  with	  HIV	  positive	  mothers	  with	  the	  aid	  of	  an	  interpreter	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• Compiled	  and	  analyzed	  data,	  drafted	  final	  report	  on	  research	  findings	  
• Findings:	  Out	  of	  pocket	  expenditure,	  especially	  informal	  payments	  to	  health	  care	  providers,	  was	  less	  than	  previously	  documented	  at	  other	  Ghanaian	  health	  care	  facilities	  	  	  
	  
Presentations	  and	  Publications	  	  Poster	  presentation,	  Summer	  Undergraduate	  Research	  Fellow	  Conference,	  Berkeley	  	   California,	  August	  2011.	  	  	   Meese,	  Halea.	  (2011).	  Demand	  Side	  Interventions	  for	  the	  Prevention	  of	  Mother	  to	  Child	  Transmission	  of	  HIV.	  Berkeley	  Undergraduate	  Journal,	  24(2).	  Retrieved	  from:	  http://escholarship.org/uc/item/48h0893f	  
	  
Professional	  Experience	  
Cynthia	  Belgum	  D.D.S.	  Davis,	  CA	  	  	  	  	  	  	  	  	  	  	  	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	   	   8/2012-­‐6/2013	  
Administrative	  Assistant	  	  	  
• Patient	  intake	  and	  vital	  signs	  	  
• Coordinated	  patient	  care	  across	  dental	  offices	  	  
• Resolved	  payment	  disputes	  with	  insurance	  companies	  and	  mediated	  patient	  payment	  concerns	  	  
	  
Emergency	  Medicine	  Scribe	  Systems,	  Sacramento,	  CA	  	   	   	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  10/2012-­‐2/2013	  	   Medical	  Scribe	  	  
• Documented	  patient	  encounters	  including	  history	  of	  present	  illness;	  review	  of	  systems;	  family,	  medical,	  and	  social	  history;	  and	  physical	  exam	  findings	  under	  the	  direction	  of	  emergency	  room	  physicians	  
	  
Berkeley	  Pulmonary	  and	  Critical	  Care	  Medical	  Group,	  Berkeley,	  CA	  	  	  	  	  	  	  	  	  	  	  	  	   6/2009-­‐3/2012	  	   Research	  Assistant	  	  
• Managed	  budgets	  for	  clinical	  trials	  using	  Microsoft	  Excel	  	  
• Organized	  scheduling	  for	  over	  20	  doctors	  working	  at	  separate	  sites	  	  
• Designed	  informational	  website	  for	  medical	  research	  
• Addressed	  concerns	  of	  pharmaceutical	  representatives	  and	  mediated	  payment	  concerns	  via	  phone,	  email	  and	  fax	  
	  
MEDICOS	  Nicaragua	  (University	  of	  California,	  Davis	  School	  of	  Medicine)	  	  	  	  	  	   5/2011-­‐6/2011	  	  
Medical	  Interpreter/Translator	  
• Interpreted	  for	  medical	  students	  during	  patient	  interviews	  and	  procedures	  at	  local	  hospitals	  and	  community	  health	  outposts	  during	  a	  one	  month	  exchange	  program	  
• Bi-­‐directional	  translation	  of	  video	  footage	  of	  interviews	  conducted	  with	  local	  health	  care	  personnel	  and	  community	  members	  used	  in	  educational	  course	  for	  medical	  residents	  
	  
Imani	  Clinic	  (University	  of	  California,	  Davis	  School	  of	  Medicine),	  Sacramento,	  CA	  	   	  	  	  	  	  	  	  	  	  	  	  6/2010-­‐7/2010	  
Medical	  Interpreter	  
• Interpreted	  for	  medical	  students,	  physicians,	  and	  Spanish	  speaking	  patients	  at	  student	  run	  clinic	  	  	  
• Assisted	  with	  patient	  intake	  and	  vital	  signs,	  organizing	  of	  medical	  supplies	  and	  medical	  charts	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Community	  Involvement	  
Physicians	  for	  Human	  Rights,	  Boston,	  MA	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1/2014–Present	  
Student	  Leadership	  Board	  Member	  
• Organized	  advocacy	  events	  including	  film	  screenings,	  clinical	  skills	  workshops,	  and	  monthly	  journal	  clubs	  
• Collaborated	  with	  board	  members	  to	  draft	  asylum	  clinic	  proposal	  	  
	  
Debate	  Mate	  USA,	  Cambridge,	  MA	  	   	  	   	   	   	  	  	  	  	  	  	  	  	  	  1/2014–Present	  
Mentor	  
• Mentored	  middle	  school	  students	  during	  bi-­‐weekly	  workshops	  on	  parliamentary	  debate	  and	  public	  speaking	  techniques	  in	  underserved	  Boston	  public	  schools	  
• Judged	  bi-­‐yearly	  local	  and	  regional	  debate	  competitions	  
	  
California	  Health	  Professional	  Student	  Alliance,	  Oakland,	  CA	  	   	  	  	  	  	  	  	  	  	  	  5/2012–5/2013	  
Northern	  California	  Education	  Officer	  
• Provided	  monthly	  educational	  briefings	  to	  chapter	  members	  on	  current	  events	  and	  research	  	  
• Collaborated	  with	  14	  member	  statewide	  officer	  corps	  to	  plan	  statewide	  lobby	  day	  and	  single	  payer	  health	  care	  conference	  for	  250	  attendees	  	  
	  
Berkeley	  Model	  United	  Nations,	  Berkeley,	  CA	  	   	   	   	  	  	  	  	  	  	  	  	  9/2008–5/2012	  
Head	  Chair	  (2011	  and	  2012),	  Co-­‐Chair	  (2009-­‐2010)	  
• Moderated	  and	  elected	  topics	  of	  discussion	  for	  committees	  of	  150+	  high	  school	  students	  
• Coordinated	  committee	  responsibilities	  with	  two	  co-­‐chairs	  	  
• Evaluated	  student	  performance	  and	  addressed	  student/adviser	  concerns	  during	  and	  prior	  to	  yearly	  conference	  
	  
Health	  and	  Medical	  Apprenticeship	  Program,	  Berkeley,	  CA	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  1/2011-­‐5/2012	  
Public	  Health	  116	  Assistant	  Coordinator	  and	  Teaching	  Assistant	  	  	  	  	  	  
• Planned	  and	  Moderated	  a	  weekly	  discussion	  on	  health	  and	  medical	  issues	  for	  of	  20	  undergraduate	  students	  	  
• Evaluated	  student	  presentations	  and	  written	  assignments	  
• Addressed	  student	  concerns	  regarding	  homework	  assignments	  and	  course	  credit	  for	  600	  student	  lecture	  	  
Awards	  and	  Honors	  	  	  Summer	  Undergraduate	  Research	  Fellowship:	  2011	  (one	  of	  40	  at	  UC	  Berkeley)	  California	  Masonic	  Scholarship:	  2008-­‐2012	  (one	  of	  20	  in	  California)	  NARFE	  (National	  Active	  and	  Retired	  Federal	  Employees	  Association)	  Scholarship:	  2008	  (one	  of	  60	  nationally)	  	  
Language	  and	  Experience	  Abroad	  
Languages	  English	  and	  Spanish	  (fluent),	  Arabic	  (basic),	  Twi	  (basic)	  
Experience	  Abroad	  6	  months	  work	  and	  study	  in	  Ghana,	  Professional	  experience	  in	  China,	  Nicaragua,	  Sierra	  Leone,	  and	  Honduras.	  
Personal	  	  	  
Interests	  Rock	  climbing	  and	  bouldering,	  Law	  and	  Public	  Policy,	  Yoga,	  Hiking,	  Travel,	  Cooking,	  and	  Downhill	  Skiing	  
 
